- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 160
Dropbox starts IPO preparations
The Salesforce Ventures-backed data storage platform is reportedly seeking underwriters for what could be the largest tech IPO since Snap.
Jul 4, 2017Razer aims for $600m in Hong Kong IPO
The gaming product and software provider is set to float in Asia, giving an exit to investors including Hangzhou Liaison Interactive.
Jul 3, 2017Delivery Hero triumphs in $1.1bn IPO
The Rocket Internet-owned Global Online Takeaway Group sold some $148m in shares, as the online food ordering platform floated at the top of its range.
Jul 3, 2017ZhongAn sets up $1.5bn Hong Kong IPO
Ping An, Tencent and the Alibaba-affiliated Ant Financial jointly own 40% of the online insurance platform, and are set to exit in an offering that could take place this year.
Jun 30, 2017Mersana makes $75m in IPO
The cancer drug conjugate developer floated in the middle of its range, in an offering that provided exits to Takeda subsidiary Millennium Pharmaceuticals and Pfizer.
Jun 29, 2017Alibaba to exit in Best IPO
Alibaba is the largest shareholder of logistics and supply chain services provider Best, which has filed for a $750m initial public offering, after raising more than $910m in VC funding.
Jun 27, 2017Shotspotter shoots to IPO
The gunfire detection technology provider floated in the middle of its range in a $30.8m IPO that gave an exit to Motorola Solutions Venture Capital.
Jun 8, 2017Aileron to align itself with public markets
Stapled peptide developer Aileron Therapeutics has filed for a $69m IPO that will allow Roche, Novartis, GlaxoSmithKline and Eli Lilly to exit.
Jun 7, 2017Delivery Hero gets set for IPO
Delivery Hero plans to issue almost $510m of shares in Germany and Luxembourg, while its largest shareholder, Rocket Internet, could sell the same number.
Jun 7, 2017Mersana swerves to public markets
The Pfizer and Takeda-backed breast cancer therapy developer has filed to raise $75m in an initial public offering that follows some $130m in equity financing.
Jun 6, 2017About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


